203 related articles for article (PubMed ID: 9050678)
1. The efficacy of drugs in the management of endometriosis.
Bulletti C; Flamigni C; Polli V; Giacomucci E; Albonetti A; Negrini V; Galassi A; Morselli-Labate AM
J Am Assoc Gynecol Laparosc; 1996 Aug; 3(4):495-501. PubMed ID: 9050678
[TBL] [Abstract][Full Text] [Related]
2. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas.
Ishihara H; Kitawaki J; Kado N; Koshiba H; Fushiki S; Honjo H
Fertil Steril; 2003 Mar; 79 Suppl 1():735-42. PubMed ID: 12620485
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
[TBL] [Abstract][Full Text] [Related]
4. Effect of GnRH agonist therapy on the expression of human heat shock protein 70 in eutopic and ectopic endometria of women with endometriosis.
Imamura T; Khan KN; Fujishita A; Kitajima M; Hiraki K; Ishimaru T; Masuzaki H
Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():16-23. PubMed ID: 25016551
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic management of endometriosis.
Saltiel E; Garabedian-Ruffalo SM
Clin Pharm; 1991 Jul; 10(7):518-31. PubMed ID: 1830521
[TBL] [Abstract][Full Text] [Related]
6. Decrease in the size of ovarian endometriomas during ovarian suppression in stage IV endometriosis. Role of preoperative medical treatment.
Rana N; Thomas S; Rotman C; Dmowski WP
J Reprod Med; 1996 Jun; 41(6):384-92. PubMed ID: 8799912
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
[TBL] [Abstract][Full Text] [Related]
8. [Studies on endocrine therapy of endometriosis].
Terakawa N
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):981-9; discussion 1000-7. PubMed ID: 2530291
[TBL] [Abstract][Full Text] [Related]
9. Distribution of heat shock proteins in eutopic and ectopic endometrium in endometriosis and adenomyosis.
Ota H; Igarashi S; Hatazawa J; Tanaka T
Fertil Steril; 1997 Jul; 68(1):23-8. PubMed ID: 9207579
[TBL] [Abstract][Full Text] [Related]
10. An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis.
Wong AY; Tang L
Fertil Steril; 2004 Jun; 81(6):1522-7. PubMed ID: 15193471
[TBL] [Abstract][Full Text] [Related]
11. Influence of ovarian endometrioma on fertility.
Ishimaru T; Masuzaki H; Samejima T; Fujishita A; Nakamura K; Yamabe T
Am J Obstet Gynecol; 1994 Aug; 171(2):541-5. PubMed ID: 8059838
[TBL] [Abstract][Full Text] [Related]
12. Influence of goserelin depot therapy on epidermal growth factor receptor expression in pelvic endometriosis.
Di Lieto A; De Rosa G; Albano G; Staibano S; Campanile M; Pontillo M; Gallo F; Micalef R; Paladini A
Gynecol Endocrinol; 1997 Feb; 11(1):17-20. PubMed ID: 9086334
[TBL] [Abstract][Full Text] [Related]
13. Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain.
Kitawaki J; Ishihara H; Kiyomizu M; Honjo H
Fertil Steril; 2008 Jun; 89(6):1831-5. PubMed ID: 17761178
[TBL] [Abstract][Full Text] [Related]
14. Combined use of a long-acting gonadotropin-releasing hormone agonist and low-dose danazol in advanced stage endometriosis.
Ugur M; Senöz S; Gökmen O
Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):155-8. PubMed ID: 8886699
[TBL] [Abstract][Full Text] [Related]
15. Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin-releasing hormone agonist.
Miller JD; Shaw RW; Casper RF; Rock JA; Thomas EJ; Dmowski WP; Surrey E; Malinak LR; Moghissi K
Fertil Steril; 1998 Aug; 70(2):293-6. PubMed ID: 9696224
[TBL] [Abstract][Full Text] [Related]
16. A randomized comparative study of the effect of leuprorelin acetate depot and danazol in the treatment of endometriosis.
Chang SP; Ng HT
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jun; 57(6):431-7. PubMed ID: 8803306
[TBL] [Abstract][Full Text] [Related]
17. Danazol for pelvic pain associated with endometriosis.
Selak V; Farquhar C; Prentice A; Singla A
Cochrane Database Syst Rev; 2000; (2):CD000068. PubMed ID: 10796483
[TBL] [Abstract][Full Text] [Related]
18. Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study.
Grow DR; Williams RF; Hsiu JG; Hodgen GD
J Clin Endocrinol Metab; 1996 May; 81(5):1933-9. PubMed ID: 8626860
[TBL] [Abstract][Full Text] [Related]
19. Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis.
Boucher A; Lemay A; Akoum A
Fertil Steril; 2000 Nov; 74(5):969-75. PubMed ID: 11056242
[TBL] [Abstract][Full Text] [Related]
20. Danazol: objective assessment in the treatment of endometriosis.
O'Shea RT; Jones WR
Clin Reprod Fertil; 1985 Sep; 3(3):205-6. PubMed ID: 2935241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
